FIELD OF INVENTION
This invention relates generally to protein-based pharmaceutical compositions, more particularly to stable formulations of multiple anti-botulism antibodies.
BACKGROUND OF THE INVENTION
Botulism is caused by botulinum neurotoxin secreted by members of the genus Clostridium and is